These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18710101)

  • 1. The evidence for stenting in femoropopliteal occlusive disease.
    Minar E; Schillinger M
    Acta Chir Belg; 2008; 108(3):292-7. PubMed ID: 18710101
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions.
    Costanza MJ; Queral LA; Lilly MP; Finn WR
    J Vasc Surg; 2004 Feb; 39(2):343-50. PubMed ID: 14743134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary nitinol stenting for femoropopliteal disease.
    Mewissen MW
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis.
    Mwipatayi BP; Hockings A; Hofmann M; Garbowski M; Sieunarine K
    J Vasc Surg; 2008 Feb; 47(2):461-9. PubMed ID: 17950563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: Outback catheter in femoropopliteal subintimal angioplasty: new horizons in treating chronic total occlusions.
    Setacci C; Sirignano P; Setacci F
    J Endovasc Ther; 2011 Feb; 18(1):22-4. PubMed ID: 21314344
    [No Abstract]   [Full Text] [Related]  

  • 6. Stenting in the femoropopliteal arterial segment.
    Mewissen MW
    Tech Vasc Interv Radiol; 2005 Dec; 8(4):146-9. PubMed ID: 16849093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
    Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
    Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
    Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
    J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iliac and femoropopliteal vascular occlusive disease treated with flexible tantalum stents.
    Strecker EP; Hagen B; Liermann D; Schneider B; Wolf HR; Wambsganss J
    Cardiovasc Intervent Radiol; 1993; 16(3):158-64. PubMed ID: 8334687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions.
    Do-dai-Do ; Triller J; Walpoth BH; Stirnemann P; Mahler F
    Cardiovasc Intervent Radiol; 1992; 15(5):306-12. PubMed ID: 1423391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New stents for SFA.
    MINAR E; SCHILLINGER M
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):635-45. PubMed ID: 19741579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses.
    Cotroneo AR; Pascali D; Iezzi R
    J Endovasc Ther; 2008 Jun; 15(3):283-91. PubMed ID: 18540701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regarding "Stenting for femoropopliteal lesions".
    Schillinger M; Minar E
    J Vasc Surg; 2008 Jul; 48(1):252; author reply 252-3. PubMed ID: 18589243
    [No Abstract]   [Full Text] [Related]  

  • 16. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of femoropopliteal patency after suboptimal duplex-guided balloon angioplasty and stenting: is recoil a bad sign?
    Ascher E; Hingorani AP; Marks N; Puggioni A; Shiferson A; Tran V; Jacob T
    Vascular; 2008; 16(5):263-8. PubMed ID: 19238867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials.
    Acin F; de Haro J; Bleda S; Varela C; Esparza L
    J Endovasc Ther; 2012 Oct; 19(5):585-95. PubMed ID: 23046322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results with the Palmaz stent in the superficial femoral artery.
    Bergeron P; Pinot JJ; Poyen V; Benichou H; Khanoyan P; Rudondy P; Wang Y; Chiarandini S; el Hussein R; Rieu R
    J Endovasc Surg; 1995 May; 2(2):161-7. PubMed ID: 9234129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after nitinol stenting in the superficial femoral and popliteal artery in an elderly population.
    Gillgren P; Pettersson H; Fernström J; Falkenberg M; Delle M; Konrad P; Lindström D
    Ann Vasc Surg; 2011 Aug; 25(6):758-65. PubMed ID: 21439769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.